Our mission at Zone Labs is to understand how diet affects hormones, genetic expression, and inflammation. With that knowledge, we can develop unique nutritional products and dietary programs that translate that understanding to consumers seeking weight loss, better health, and improved athletic performance.
Dr. Barry Sears founded Zone Labs in 1999 based on the discoveries he made on the role of diet in hormonal response, gene expression, and inflammation. The company has established a leadership position in the areas of high-purity omega-3 fatty acid concentrates, patented food products for improved hormonal control and satiety, and anti-inflammatory polyphenols. These products are used in diverse areas, such as weight loss, improved health, and athletic performance. Zone Labs is also international in scope with operations through its foreign partners in Japan, Italy, Spain, Germany, Greece, Austria, Mexico, and Chile.
Dr. Barry Sears
Dr. Barry Sears is a leading authority on the impact of the diet on hormonal response, genetic expression, and inflammation. A former research scientist at the Boston University School of Medicine and the Massachusetts Institute of Technology, Dr. Sears has dedicated his research efforts over the past 30 years to the study of lipids. He has published more than 30 scientific articles and holds 13 U.S. patents in the areas of intravenous drug delivery systems and hormonal regulation for the treatment of cardiovascular disease. He has also written 13 books, including the New York Times #1 best-seller "The Zone". These books have sold more than 5 million copies in the U.S. and have been translated into 22 different languages. For further information on the scientific background of Dr. Sears, click here.
Scientific Advisory Board
Although the research at Zone Labs is headed by Dr. Sears, we make extensive use of our Scientific Advisory Board to provide research on the latest breakthroughs in biotechnology from a diverse number of fields.
Carol Johnston, PhD
Carol Johnston, PhD is professor of Nutrition at Arizona State University and director of the Nutrition Program. She received the Grace Goldsmith Award for significant achievements in the field of nutrition by a scientist under the age of 50 years sponsored by the American College of Nutrition in 2004 and the Mark Bieber Professional Award sponsored by the American College of Nutrition for academic accomplishments in 2008. Her research areas include vitamin C and dietary interventions in obesity and diabetes. She has more than 75 scientific publications.
Don Layman, PhD
Don Layman, PhD is professor emeritus of Nutrition in the Department of Food Science and Human Nutrition at the University of Illinois. He is recognized as one of the leading researchers in the role of branched-chain amino acids in the treatment of obesity, type 2 diabetes, and enhancement of protein synthesis. He has published more than 80 scientific publications.
Robert McNamara, PhD
Robert McNamara, PhD is an associate professor of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine, Division of Bipolar Disorders Research. Dr. McNamara is director of the Lipidomics Research Program, which investigates the role of fatty acids in the pathoetiology and treatment of recurrent neuropsychiatric disorders using animal models, postmortem brain tissue, and preclinical and clinical neuroimaging techniques. His lab is currently investigating the effects of omega-3 fatty acid supplementation on functional brain activation patterns and symptom severity in children and adolescents with or at high risk for mood disorders associated with elevated inflammation, including major depressive disorder and bipolar disorder. Dr. McNamara has more than 100 peer-reviewed publications.
Camillo Ricordi, MD
Camillo Ricordi, MD is one of the world’s leaders in cell transplantation for the treatment of diabetes. He is the Stacy Joy Goodman Professor of Surgery, distinguished professor of Medicine, professor of Biomedical Engineering, and Microbiology and Immunology, and serves as scientific director and chief academic officer of the University of Miami Diabetes Research Institute. He has authored more than 600 scientific publications and has been awarded 11 patents.